Eton Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary

Eton Pharmaceuticals

16/03/2023 21:02

* Eton Pharmaceuticals Inc  ETON.OQ  reported quarterly
adjusted
earnings of 4 cents​​ per share for the quarter ended in
December. The lone analyst forecast for the quarter was
for earnings of one cent per share.
    * Revenue rose 39.5% to $8.50 million from a year ago;
analysts
expected $9.12 million. 
    * Eton Pharmaceuticals Inc's reported EPS for the quarter
was 4
cents​.
    * The mean earnings estimate of analysts had risen by
about 200%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Eton Pharmaceuticals Inc shares had risen by 34.8% this
quarter.
    * The company reported quarterly net income of $912
thousand.
    * Wall Street's median 12-month price target for Eton
Pharmaceuticals Inc is $10.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 16 at 09:01 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      0.01           0.04           Beat
 Sep. 30 2022      -0.15          -0.12          Beat
 Jun. 30 2022      0.03           -0.06          Missed
 Mar. 31 2022      -0.08          -0.21          Missed